Latest Tariff Impact News

Page 7 of 7
Ansell Limited delivered a robust FY25 half-year performance, marked by double-digit sales and earnings growth, successful KBU acquisition integration, and an upward revision of adjusted EPS guidance.
Ada Torres
Ada Torres
10 Feb 2025
Ansell Limited reports robust FY25 half-year results, driven by strong organic sales and EBIT growth, while accelerating its KBU integration and productivity initiatives.
Ada Torres
Ada Torres
10 Feb 2025
Fisher & Paykel Healthcare anticipates increased costs from newly imposed US tariffs on imports from Mexico and China, potentially delaying its gross margin recovery timeline but expects no immediate profit impact for FY2025.
Ada Torres
Ada Torres
3 Feb 2025